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Abstract
Tumorhead (TH) is a maternally expressed gene in Xenopus laevis, that when overexpressed, increased proliferation of ectodermal
derivatives and inhibited neural and epidermal differentiation. However, injection of anti-TH antibodies inhibited cleavage of all blas-
tomeres, not only those contributing to the ectoderm. The injection of TH morpholino antisense oligonucleotide (TH-MO), which inhibits
translation of TH mRNA, did not affect early cleavage but inhibited cell division in both the neural field and epidermis. This was
accompanied by the inhibition of neural and epidermal markers. TH-MO did not affect the formation and differentiation of mesoderm and
endoderm derivatives. Our overexpression and loss-of-function studies demonstrated that TH plays an important role in differentiation of
the ectoderm by regulating cell proliferation. They also supported the conclusion that the maternal component of TH may affect the cell
cycle in all cells, while the zygotic component has a germ layer-specific effect on the ectoderm.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
An important problem in embryology is understanding the
mechanism involved in specification and differentiation of the
embryonic germ layers. In Xenopus laevis, the endoderm and
mesoderm are both thought to be specified initially through the
elaboration of the maternal program (reviewed in Clements et
al., 2001; Chan and Etkin, 2000; Harland and Gerhart, 1997;
Xanthos et al., 2001). At the midblastula transition, the zygotic
genetic program is initiated which further defines the germ
layers in terms of their differentiation and patterning. In the
differentiation of the ectoderm BMPs and GDF subfamilies of
TGF-, ligands bias the ventral ectoderm of the gastrula to
adopt an epidermal cell fate. Differentiation of the epidermis is
further directed by the expression of BMP/GDF-induced
downstream genes, such as Xvent 1 and-2, Xmsx1, and
GATA1 (Ault et al., 1997; Chang and Hemmati-Brivanlou,
1998, 1999; Suzuki et al., 1997; Weinstein and Hemmati-
Brivanlou, 1999; Xu et al., 1997). On the dorsal side, however,
ectodermal cells are blocked from BMP/GDF signaling by
antagonizers from the organizer (reviewed in Harland and
Gerhart, 1997). The absence of BMP/GDF signaling and the
existence of growth factor signaling, such as those from the
fibroblast growth factor (FGF) pathway, cause naı¨ve ectoder-
mal cells to adopt a neural fate (Sasai and De Robertis, 1997).
Neurogenesis is accomplished by the actions of basic helix–
loop–helix (bHLH) proneural genes, such as Xngnr1, which
determines the neuronal precursor cells (Ma et al., 1996), and
neuroD (Lee et al., 1995), which determines the final fate of
neurons (Ma et al., 1996). Following the action of proneural
genes, the neurogenic genes Notch and Delta underlie the
lateral inhibitory process and finally determine the subset of
neuronal cells resulting in a “salt-and pepper” pattern of neu-
ronal differentiation. The members of Sox family and gli/zic
family transcription factors usually work as a mediator or
coordinator with the proneural genes (Bellefroid et al., 1996;
Brewster et al., 1998; Lamar et al., 2001; Nakata et al., 1997;
Sasai, 1998).
Although the induction and differentiation of neural and
epidermal cells have been extensively studied, how the mater-
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nal and zygotic programs of gene expression are integrated into
the specification and differentiation of the ectoderm is still
unclear. We reported that a maternally expressed gene, Tumo-
rhead (TH), when overexpressed in the embryo, inhibited neu-
ral and epidermal differentiation but not specification of the
ectodermal germ layer or its bifurcation into epidermis or
neural fate (Wu et al., 2001). We also found that the effect of
TH was due to the ability of overexpressed TH to stimulate cell
proliferation, resulting in the inability of the ectodermally de-
rived cells to differentiate. However, we also found that the
loss-of-function of the maternal TH protein with anti-TH an-
tibodies resulted in a general inhibition of cleavage of all
blastomeres (Wu et al., 2001). These results suggested the
possibility that there may be a difference in the role of the
maternal and zygotic components of TH.
To address this issue, we used a loss-of-function approach
involving the injection of TH morpholino antisense oligonu-
cleotides (TH-MO). Morpholino antisense oligonucleotides
function by inhibiting translation of the cognate mRNA. Since
there is a substantial maternal store of TH protein, our rationale
was that TH-MO would affect translation of the residual TH
maternal mRNA as well as the zygotic TH transcripts. Thus,
any phenotype would be due to interfering with the translation
of any low level of maternal mRNA and the zygotic TH
mRNA. We found that the TH-MO phenotype was character-
ized by an increase in cell size and inhibition of cell division in
both the neural field and epidermis. This was accompanied by
inhibition of the expression of several neural and epidermal
differentiation markers and formation of ciliated cells in the
epidermis. TH-MO did not interfere with mesoderm or
endoderm development. Both our overexpression and loss-of-
function studies therefore demonstrate that TH is involved in
regulating ectodermal differentiation through its control of cell
proliferation. They also suggest that the maternal component
of TH protein may regulate proliferation of all cells, while the
zygotic component is restricted to regulating proliferation of
the ectoderm. These results support the conclusion that TH has
both general maternal and a zygotic germ layer-specific func-
tion during development.
Materials and methods
TH-MO and the rescue mRNAs
The 25-mer of TH-MO CCTAGCAGAAATGGTGG-
GAATACTT was designed and synthesized commercially
(Gene Tools Company, Philomath, OR) based on the TH
Fig. 1. Levels of TH protein decrease in TH-MO injected embryos. The level of TH protein was measured on Western blots by using the anti-TH GN114
polyclonal antibody. (A) Stage 10 gastrula and stage 15 neurula embryos. Lane 1, the increased level of TH protein in embryos injected with TH mRNA;
Lane 2, TH mRNA plus TH-MO-injected embryos showing inhibition of large amount of exogenous synthesis; Lane 3, level of TH protein in control
noninjected embryos; Lane 4, level of TH protein in TH-MO-injected embryos. Stage 15 embryos. Lanes 1–4 were the same as in stage 10 embryos. (B)
Graphic representation of the results in (A).
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cDNA sequence. Nucleotides with bold letters were
changed in the mutant cDNA for the rescue experiment. The
translation initiation codon ATG is underlined. To synthe-
size the mutant TH mRNAs for the rescue experiment, two
expression plasmids, pCS2  MT  THM1 (M1) and pCS2
 MT  THM2 (M2), were made in a polymerase chain
reaction (PCR) by using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). The primers for
the site mutations are as follows: for M1 forward,
5-CCTAGCAGAAATGGTcGGtATtCTaCCTGGCTCTA-
CAGAC; for M1 reverse, 5-GTCTGTAGAGCCAGGtA-
GaATaCCgACCATTTCTGCTAGG; and for M2 forward,
5-GCAGAAATGGTGGGtATtCTaCCTGGCTCTACAG-
ACAC; for M2 reverse, 5-GTGTCTGTAGAGCCAGGtA-
GaATaCCACCATTTCTGC, respectively. The M1 cDNA
contains four and M2 cDNA contains three same-sense
mutations in the TH-MO region, which are indicated by
boldface lowercase letters. The mRNAs produced with the
mutant cDNAs avoid binding to TH-MO but produce a
wild-type TH protein due to the same-sense mutations.
Synthetic M1- and M2-capped mRNAs were prepared ac-
cording to the method of El-Hodiri et al. (1997). As a
control morpholino, we used the standard morpholino oligo
(SC-MO), which is supplied by Gene Tools. This control
MO hybridizes only to incorrectly spliced -globin mRNAs
in thallasemic humans.
In vitro translational
In vitro translation was done with TNT Coupled Reticu-
locyte Lysate Systems (Promega). Each reaction was 25 l
and contained 1 g of RNA or a mixture of 1 g of RNA
and 1 g of TH-MO. The translational products were la-
beled with 35S-Met. A total of 12 l of each reaction was
analyzed with 12% of SDS–PAGE.
Microinjection of embryos
Embryo handling and RNA injection were carried out
according to the method of El-Hodiri et al. (1997). Briefly,
Fig. 2. TH-MO induces neural defects in the developing nervous system. Embryos were injected with 15 ng of TH-MO or SC-MO (morpholino standard
control) along with rhodamine as a lineage tracer into the animal/dorsal blastomere at the two- to eight-cell stages. Injected embryos were analyzed at stages
17 and 21. (A) and (B) are control SC-MO-injected, and (C) and (D) are TH-MO-injected stage 17 embryos showing abnormal neural folds on the side
injected with TH-MO. The red lineage tracer shows the region of the embryo injected. (E, F) Sections of control SC-MO-injected embryos. (G, H)
TH-MO-injected embryos. The arrows in (G) point to the abnormal neural fold region. (I) A stage 21 SC-MO-injected control embryo showing the normal
cement gland development. (J, K) TH-MO-injected embryos showing failure of neural tube closure on the injected side and defective cement glands (arrows).
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8 –15 ng of TH-MO was injected into Xenopus embryos
at two- to eight-cell stages. Rhodamine-conjugated dex-
tran (MW 10,000; Molecular Probes, Eugene, OR) was
used as a lineage tracer in most of the injections. For
examining the future neural plate, one animal/dorsal blas-
tomere was injected at the eight-cell stage; for examining
the epidermis, one animal/ventral blastomere was in-
jected; for examining the mesoderm, the dorsal or ventral
marginal zone (MZ) was injected; and for examining the
endoderm, injection was randomly done into the vegetal
pole (Dale and Slack, 1987; Moody, 1987a, 1987b). In
the rescue experiments, embryos were injected with a
mixture of 5 ng of either M1 or M2 mRNA with 15 ng of
TH-MO and with 5–10 ng of rhodamine. As controls,
embryos were injected with the same amount of either
TH-MO or mRNA (M1 or M2).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was carried out ac-
cording to the method of Kloc and Etkin (1999) and Harland
(Harland, 1991). Digoxigenin-labeled probes were gener-
ated by in vitro transcription reaction. Probes consisted of
Xkrox 20 (gift of D. Wilkinson), E-keratin (gift of T. Sar-
gent), Engrailed (gift of A Hemmatti-Brivanlou), Xotx (gift
of I. Blitz), N-tubulin (gift of K. Kintner), and alpha-T4
globin (gift of R. Patient).
Immunocytochemistry and histology
Whole-mount immunocytochemistry was performed ac-
cording to the method of Kloc and Etkin (1998) and Carl
and Klymkowsky (1999). The injected embryos were fixed
with MEMFA for 2 h and treated with Dent’s fixative
overnight. The embryos were bleached with 10% hydrogen
peroxide in Dent’s fixative, if needed. Anti-acetylated-tubu-
lin monoclonal antibody (Sigma Chemical Co., St. Louis,
MO) was used to stain ciliated cells; anti-skeletal muscle
monoclonal antibody 12/101 [Developmental Studies Hy-
bridoma Bank (DSHB), University of Iowa, Iowa City, IA]
was used to visualize the somites; and anti-phosphorylated
histone H3 antibody (Upstate Biotechnology, Lake Placid,
NY) was used to visualize the mitotic nuclei. The concen-
tration of first antibody was 1–3 g/ml. Alkaline phos-
phatase-conjugated goat anti-mouse IgG (Calbiochem, La
Jolla, CA) was used as the second antibody at a concentra-
tion of 1:3000.
The histology studies were carried out according to the
method of Kelly et al. (1991). Harris’ hematoxylin solution,
modified (HHs-16; Sigma), and eosin Y solution, alcoholic
(HT110-1-16; Sigma), were used for the hematoxylin–eosin
(H&E) staining. Staining was carried out according to the
manufacturer’s instructions.
Immunoblotting
Immunoblotting was performed with the anti-TH peptide
rabbit serum (GN114, at 1:1000 dilution; Wu et al., 2001) or
immunopurified GN114 antibody (at 4 g/ml).
Results
TH-MO induces defects in the developing nervous system
TH-MO (15 ng) was injected into one blastomere at
the two-cell stage or into one of the dorsal/animal blas-
tomeres at the eight-cell stage. In all experiments,
TH-MO was coinjected with rhodamine to follow the
lineage that contained the morpholinos. To determine the
effectiveness of the TH-MO on the level of endogenous
TH protein, we analyzed TH-MO-injected embryos at the
gastrula and neurula stages for TH protein levels. Fig. 1
shows that the TH-MO resulted in a significant decrease
in the level of endogenous TH protein by stages 10 –15.
This corresponds to the timing of the appearance of the
phenotype. In these experiments, TH-MO was injected
into the future dorsal blastomeres; therefore, inhibition of
translation occurred only in the injected blastomeres ac-
counting for only a decrease instead of an absence of the
TH protein.
Injected embryos developed normally until the neurula
stage, when the neural fold on the injected side failed to
form and fold properly (Fig. 2A–D). Sections of these
embryos showed that the injection of standard morpholino
control oligonucleotides (SC-MO) had no effect on the
morphology of the neural folds, while the epithelium of the
TH-MO-injected side of the embryo remained flattened and
appeared to have cells that were larger in size than those of
the noninjected side (Fig. 2E–H). In addition, the cement
gland, which is derived from the ectoderm, also did not
form on the injected side (Fig. 2I–K).
At the tadpole stage, loss of TH function resulted in
abnormalities in brain development, which was accompa-
nied by severe eye defects (Fig. 3A–C). The latter was
probably a secondary defect caused by abnormalities in the
developing brain that inhibited proper morphogenesis of the
optic cup and subsequent lens induction. Sections of tad-
poles revealed that, within the TH-MO-injected region of
the brain, the cells were disorganized, rounder in shape, and
embryonic in nature containing large numbers of yolk plate-
lets (Fig. 3D and E). On the other hand, cells on the unin-
jected side were typical neural cells organized into normal
brain structures (Fig. 3E). In sagittal sections, the abnormal
cells extended throughout the length of the brain of the
TH-MO-injected side (Fig. 3F and G). This result demon-
strates that loss of TH function results in major defects in
the development of the nervous system.
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TH-MO induces defects in the future epidermis
To assess the effect on the differentiation of the epi-
dermis, TH-MO was injected into the animal/ventral
blastomeres at the eight-cell stage. Injected embryos did
not show any visible abnormalities until the late neurula
stage to tailbud stage. In TH-MO-injected embryos, the
epidermis showed a disorderly arrangement of pigmented
cells, including pigment cell aggregation when compared
with control SC-MO-injected embryos (Fig. 4A–F). They
also possessed regions of abnormal pigment distribution
(Fig. 4D).
Inhibition of TH inhibits epidermal and
neural differentiation
To further characterize the involvement of TH in devel-
opment of the ectoderm, we analyzed expression of the
epidermal differentiation marker gene E-keratin (Jonas et
al., 1985) in TH-MO-injected embryos. We also examined
the effect of TH-MO on formation of ciliated cells in the
epidermis using acetylated tubulin as a marker for these
cells (LeDizet and Piperno, 1991). Ciliated cells originate
from the inner layer of the epidermis and move to the outer
layer once they have finished differentiating at stage 23,
Fig. 3. TH-MO affected neural development at tadpole stages. Embryo injection and analyses were done as described in Fig. 1. (A) Stage 45 control embryo
showing normal craniofacial and eye development. The dotted line represents the midline. (B, C) A stage 45 TH-MO-injected embryo showing abnormal
craniofacial and eye development on the injected side. (D) A section of a control SC-MO-injected stage 35 embryo. (E) A stage 45 TH-MO-injected embryo
showing abnormal neural development and eye formation on the injected side (arrow and asterisk, respectively). The panel on the left shows the morphology
of control uninjected side of this embryo, while the panel at the right shows the abnormal morphology and cellular structure of the injected side. Notice the
large yolk platelets remaining in these cells, suggesting their embryonic nature. (F) A transverse section of a stage 35 control SC-MO-injected tadpole
showing normal brain development. (G) A similar tadpole showing abnormalities in the injected side of the embryo (arrows).
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making this a criterion for epidermal differentiation (Deb-
landre et al., 1999). Fig. 4G–I shows by in situ hybridization
that the expression of E-keratin mRNA was inhibited on the
TH-MO-injected side of the embryo. Furthermore, immu-
nostaining showed that alpha-tubulin-positive ciliary tufts
were fewer and smaller on the TH-MO-injected side than
those on the uninjected side, supporting the conclusion that
inhibiting TH function affects epidermal differentiation
(Fig. 4J–L).
To determine how inhibiting TH function affects neural
development and differentiation, we examined the expres-
sion of several brain markers, including Engrailed (Hem-
mati-Brivanlou et al., 1991), OTX (Kablar et al., 1996), and
Krox-20 (Bradley et al., 1993), along with the neuronal
differentiation marker gene neuron-specific--II-tubulin (N-
tubulin; Richter et al., 1988). Our results showed that
TH-MO inhibited or significantly decreased the expression
of all of these markers on the injected side of the embryo
(Fig. 5A–G). These results indicate that loss of TH function
inhibits neural and epidermal differentiation.
TH-MO does not affect mesoderm and
endoderm development
It is possible that the neural abnormalities induced by
TH-MO arose from defective mesoderm since signals from
mesoderm are important in neural development (Gamse and
Sive, 2000; Sasai and De Robertis, 1997). To test this
possibility, TH-MO was injected into blastomeres of eight-
cell-stage embryos that give rise to the mesoderm (Dale and
Slack, 1987; Moody, 1987a, 1987b. As a control, a mixture
of the same amount of a morpholino standard control (SC-
MO) and rhodamine was injected into a group of sibling
embryos. In situ hybridization analysis showed that there
was no effect on the expression pattern of the mesoderm
markers goosecoid and Xbra, nor were there any morpho-
logical abnormalities during gastrulation in either SC-
MO-or TH-MO-injected embryos (data not shown).
To determine further the effect of TH-MO on the meso-
derm, we examined the expression of the skeletal muscle
marker 12/101 by immunostaining and the ventral meso-
derm marker -T4globin by in situ hybridization at the
tailbud stages. In all cases, there was no effect of TH-MO
on the expression of any of these mesodermal markers or on
general mesoderm morphology and development (Fig. 6A–
G). These results demonstrated that loss of TH function
does not affect the mesoderm, which is consistent with the
results of our overexpression study (Wu et al., 2001).
We also tested whether loss of TH function interferes
with endoderm development by injecting TH-MO into the
vegetal blastomeres of the embryo. In all cases, the TH-
MO-injected embryos developed normally with no morpho-
logical effects on endoderm development (Fig. 6H and I).
The results demonstrate that loss of TH function had no
effect on either mesoderm or endoderm, indicating that the
neural defects produced by TH-MO arose from the ecto-
derm itself.
TH mRNA rescues the TH-MO phenotype
To establish the specificity of the TH-MO phenotype, we
performed an experiment in which we rescued the TH-MO
phenotype by injection of TH-mRNA. Because TH-MO is
designed to interact with the translation initiation region of
the wild-type TH mRNA, we used two mutant TH mRNAs
for the rescue experiment. The mutant TH mRNAs M1 and
M2 were mutated within the MO binding site to inhibit MO
binding, but were able to produce wild-type TH protein (see
Materials and methods). The effectiveness of the TH-MO to
inhibit translation was demonstrated by the inhibition of
translation of the wild-type TH mRNA in a cell-free trans-
lation system, while the rescuing mutant TH mRNAs M1
and M2 were not inhibited (Fig. 7A). In the rescue experi-
mental group, embryos were injected with a mixture of TH
mRNA (M1 or M2) and TH-MO. The same dose of either
TH mRNA or TH-MO alone was also injected into groups
of sibling embryos as a control. Rescue was scored on the
basis of normal neural fold formation and cement gland
differentiation in the TH-MO/mRNA-injected embryos.
The embryos were scored at stage 21, since defective neural
folds and cement gland were clearly observed at this time.
Embryos injected with TH-MO alone showed the defective
neural folds and cement glands when compared with control
embryos (Fig. 7B–D). The defects occurred in 71.8% of the
embryos (Fig. 7I). Embryos injected with M1 or M2 TH
mRNA alone showed neural expansion consistent with the
overexpression phenotype (data not shown; Wu et al.,
2001). In embryos injected with TH-MO plus M1 or M2 TH
mRNA, normal cement glands and well-formed neural folds
were observed (Fig. 7E–H). The percentage of normal em-
bryos in M1 and M2 mRNA-rescued embryos was 63.6 and
66.6%, respectively (Fig. 7I). These results indicated that
both M1 and M2 TH mRNAs were equally able to rescue
the TH-MO phenotype and that the specificity of the
TH-MO phenotype was the result of TH-MO effects on the
endogenous TH gene product.
TH-MO inhibits cell proliferation in the ectoderm
Overexpression of TH results in an increase in cell pro-
liferation (Wu et al., 2001). Based on this and the morphol-
ogy of cells in TH-MO-injected embryos, we hypothesized
that inhibiting TH function would inhibit cell proliferation
in the ectoderm. Therefore, we examined proliferation in
TH-MO-injected embryos by immunostaining with anti-
phosphorylated histone H3 antibody (p-H3 ab). Histone H3
is specifically phosphorylated from the late G2 to the M
phase of the cell cycle, thus phosphorylated H3 is a reliable
mitotic marker (Hendzel et al., 1997; Saka and Smith,
2001). Fig. 8 shows that, at stage 21, the number of p-H3
ab-positive nuclei was decreased on the TH-MO-injected
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side of the embryo when compared with the control unin-
jected side. This result confirmed that TH-MO inhibits cell
division in the ectoderm and suggests that the enlarged cells
observed in the TH-MO-injected neural and epidermal tis-
sue were due to the inhibition of cell division. This is
consistent with the finding of our overexpression study, in
which we observed that TH mRNA increased the rate of cell
division (Wu et al., 2001).
Discussion
TH is involved in differentiation of the ectoderm through
its effect on cell proliferation
Our data demonstrate that TH is an important component
of a molecular pathway involved in the differentiation of the
ectoderm. The data are also consistent with the idea that this
Fig. 4. TH-MO induces defects in the epidermis and inhibits epidermis differentiation. Embryos were injected into the animal/ventral blastomere (future
epidermis). TH-MO-injected embryos did not show any visible abnormalities until the late neurula stage to tailbud stages. (A–C) Control SC-MO-injected
embryos at stage 25. (D–F) TH-MO-injected embryos showing abnormalities in pigment aggregation (arrow). The arrows in (D) and (F) point to abnormalities
in the epidermis. (G–I) A stage 17 embryo analyzed by in situ hybridization with a probe for epidermal keratin. Arrow in (H) points to a region where
E-keratin mRNA is inhibited by TH-MO. (G) The uninjected side of the embryo. (I) Rhodamine distribution in the embryo shown in (H). (J–L) A stage 23
embryo that was analyzed by immunostaining with an antibody 11 6B-I against acetylated alpha-tubulin. (J) The control uninjected side of the embryo. (K)
TH-MO-injected side of the embryo. Alpha-tubulin-positive ciliary tufts are fewer and smaller on the TH-MO-injected side, indicating that TH-MO interfered
with ciliated cell differentiation.
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Fig. 5. TH-MO inhibits neural differentiation. (A) TH-MO-injected embryos analyzed by in situ hybridization for the neural differentiation marker Engrailed.
(B) Embryos injected with TH-MO. (C, D) Embryos analyzed for OTX expression. (C) A TH-MO-injected embryo showing that OTX expression is inhibited
on the injected side. (D) An uninjected control embryo showing the normal OTX expression pattern. (E) TH-MO-injected embryos analyzed for Krox 20.
This also shows inhibition by TH-MO injection. Control is shown in (F). Arrows in (A, C, and E) are pointing to the region of reduced expression. (G)
TH-MO-injected embryo showing the effect on expression of N-tubulin. Panel on right shows distribution of the rhodamine lineage tracer. Arrow in left
panels points to area of reduced N-tubulin expression.
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Fig. 6. TH-MO does not affect mesoderm and endoderm development. TH-MO or SC-MO with rhodamine was injected into the region of the marginal zone
(A–D) or at the vegetal pole (E–I) at the eight-cell stage. (A, B) Injected with SC-MO; (C, D) Injected with TH-MO. (B, D) Analyzed by in situ hybridization
with alpha-T4 globin in situ probe. (E) Embryos that were injected at the vegetal pole with the TH-MO. (F) An H&E-stained section through the middle region
of the TH-MO-injected embryo. (G) A TH-MO-injected embryo analyzed by immunostaining with the 12/101 antibody against skeletal muscle. (H) Tadpoles
that were injected in the vegetal pole region with the SC-MO. (I) Tadpoles that were injected in the vegetal pole with the TH-MO. The distribution of
rhodamine is shown in the right panel.
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pathway regulates cell proliferation, thus suggesting an im-
portant link between the process of cell proliferation and
differentiation of the ectoderm. Interestingly, both gain-of-
function, through overexpression, and loss-of-function us-
ing morpholinos produced a seemingly similar effect on
inhibiting differentiation of the ectoderm. However, for
overexpression, the cells derived from the ectoderm are
maintained in a constant state of proliferation, preventing
them from differentiating, while in the TH-MO loss-of-
function experiments, the cells are inhibited from dividing
before they move into the neural or epidermal pathway. The
net effect in both instances is that cells do not to differen-
tiate along either the neural or epidermal pathways; how-
ever, mechanistically, the reasons for this inhibition are
different.
The conclusion demonstrating the link between cell pro-
liferation and differentiation is supported first by the obser-
vation that inhibition of differentiation by gain or loss of TH
function is always coupled with an increase or decrease in
cell proliferation. Second, inhibiting cell division in TH-
overexpressing embryos by treating TH mRNA-injected
embryos with the cell division inhibitors hydroxyurea and
aphidicolin (HUA) also restored neuronal differentiation
(Wu et al., 2001). Cell cycle regulation is unlikely to play an
instructive role in cell fate determination; nevertheless, it
might perform a critical permissive function in differentia-
tion by restricting the developmental paths available to the
progenitor at a given point in time. The behavior of TH in
regulating ectodermal proliferation and differentiation can
be explained by this mechanism. Other genes linking pro-
liferation and ectoderm differentiation include the home-
odomain transcription factor Xoptx2 (Zuber et al., 1999),
winged helix transcription factor XBF-1 (Bourguignon et
al., 1998; Hardcastle and Papalopulu, 2000), and the cyclin-
dependent kinase (Cdk) inhibitor p27xic1 (Ohnuma et al.,
1999). Overexpression of Xoptx2 enlarges the eye and brain
field by promoting cell proliferation without interfering with
differentiation. This is different from the effect of overex-
pression of TH. In addition, unlike the TH protein, XBF-1
induces or inhibits cell proliferation in a dose-dependent
manner. A high dose of XBF-1 represses the expression of
p27Xic1 and thus promotes cell proliferation. Conversely, a
low dose of XBF-1 induces the expression of p27Xic1 and
thus inhibits cell proliferation. Therefore, TH appears to be
operating through a different molecular pathway than either
of these genes in regulating the differentiation of the ecto-
derm.
A possible difference between maternal and
zygotic TH function
TH is a maternal gene product, and its protein product is
detected in all cells of the embryo (Wu et al., 2001), albeit
the zygotically expressed TH mRNA is expressed strongly
in the neural plate (C.F.W. and L.D.E., unpublished obser-
vation). We have observed that injection of anti-TH anti-
body (TH ab) into immature oocytes inhibits progesterone-
induced maturation (C.F.W. and L.D.E., unpublished
observations), while injection of anti-TH ab into embryos at
early stages inhibited embryonic cleavage in all injected
blastomeres (Wu et al., 2001). The injection of anti-TH
antibodies inhibits the function of the maternal store of TH
protein, indicating that this component of TH functions as a
general regulator of embryonic cell division. However, loss-
of-function using TH-MO affects proliferation only in the
ectoderm and its derivatives. As opposed to the TH anti-
body, TH-MO inhibits new TH mRNA translation. There-
fore, the TH-MO would not affect the function of the ma-
ternal store of the TH protein, but instead would inhibit the
translation of any zygotically synthesized or residual ma-
ternal TH mRNA. These results suggest that loss of zygotic
TH gene function has a specific effect on proliferation
within the ectoderm, while loss of maternal TH function has
a general effect on cell proliferation of the embryonic blas-
tomeres. It is unclear whether these effects on proliferation
occur through the same or different signaling pathways.
This will be an important issue to address. It does, however,
support an important role for TH in regulating cell prolif-
eration and fundamental cell cycle events during develop-
ment.
This raises the interesting question of the mechanism by
which TH produces the germ layer-specific effect on pro-
liferation since it is ubiquitous throughout early develop-
ment. One possibility is that TH protein, although present in
all germ layers, only functions in the ectoderm after the
midblastula transition. Alternatively, TH may function
through interaction with different partners in different re-
gions of the embryo and may serve functions other than
proliferation in the mesoderm and endoderm. In our analy-
sis, the most obvious phenotype is its effect on proliferation
and differentiation of the ectoderm. Other phenotypes may
Fig. 7. TH mRNA rescues the TH-MO phenotype. (A) TH-MO inhibits translation of wild type TH mRNA but not the mutant form. In vitro translation of
TH mRNA and TH mutant mRNAs M1 and M2 were carried out according to Materials and methods. Lane 1, Wild-type TH mRNA translation product.
Lanes 2 and 3. Translation products of mutants M1 and M2, respectively. These possess the cmye-epitope tag accounting for the difference in size from that
of the wild-type TH protein in lane 1. Lane 4, Inhibition of wild-type TH mRNA using the TH-MO. Lanes 5 and 6, show that translation of the mutant forms
M1 and M2 of the TH mRNA is not affected by TH-MO. (B–I) TH-MO, mutant TH mRNA (M1 or M2), or a mixture of TH-MO with TH mRNA was injected
into embryos. (B) Control noninjected embryos at stage 21. (C) TH-MO-injected embryos showing defective neural folds (arrow) and cement gland
(arrowhead). (D) Rhodamine tracer showing overlap between affected region and presence of TH-MO. (E–H) Embryos injected with the mixture of TH-MO
and TH mRNA (M1 or M2) showing the rescued neural folds (arrows) and cement gland (arrowheads). (F, H) Rhodamine lineage tracer. (I) A histogram
of the rescue experiment.
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be too subtle to detect or there are redundant pathways in
mesoderm and endoderm that can substitute for TH func-
tion.
It is known that cell division rates are different in the
various regions, germ layers, and tissues during early de-
velopment. For example, from the gastrulation to tailbud
stages, cells in the dorsal mesoderm, including notochord
and somites, divide very slowly after the midblastula tran-
sition (MBT) (Hartenstein, 1989; Saka and Smith, 2001).
These germ layers may possess enough maternal TH to
support cell division. An increase in TH protein by overex-
pression would not affect their development. Therefore,
injection of TH mRNA or TH-MO would not affect the
proliferation of these cells and we would not detect an
obvious phenotype. The ectoderm, in contrast, is the most
actively dividing part of the embryo at this time, and as
such, either overexpression or loss-of-function would affect
cell division and subsequent differentiation (Hartenstein,
1989; Saka and Smith, 2001).
In normal differentiation of the ectoderm, the cells must
withdrawal from the cell cycle and differentiate. Wu et al.
(2001) reported differences in the nuclear cytoplasmic par-
titioning of TH protein during development. We have ob-
served that, in cells of regions that are proliferating, TH
appears to be in the cytoplasm, while in cells that may be
withdrawing from the cell cycle, it is nuclear (Larabell,
C.F.W., and L.D.E., unpublished observations). This differ-
ence in subcellular partitioning may reflect how the protein
functions in regulating proliferation in the different germ
layers to produce a regional effect. This will, of course,
require careful analysis regarding the relationship between
the cell cycle and TH protein localization.
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